Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @MedimixInt
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @MedimixInt
-
If you are looking for
#RWE in Oncology & Hematology, we have more than 350,000 patients records readily available in AML, CLL, CML, ALL, MM ... and more. We can also collect live upon your need in more than 50 countries in 24+ indications. Meet us at#ASH19pic.twitter.com/TpcxYQ6cpk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In need of historical data? Within 48 hours, we can provide you with patient charts, each including 100+ data points. Here is an example of an insight for Gastric Cancer in Japan RWD Oct 2018-Oct 2019. Historical Data available in 22+ indications and 50+ countries.pic.twitter.com/JulgfgU2wT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ESMO starts tomorrow! Medimix International is primed to show August RWD in 22 oncology/hematology indications, reported from EMRs by our global HCP panel in our LiveTracker series. Ask about our OfftheShelf historical data. Hope to see you there at Evidera booth #241!
#ESMOpic.twitter.com/SlkDgctrj0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Almost time for ESMO! Medimix has August data to share from our LiveTrackers for oncology and hematology, reported from EMRs by our global HCP panel. Ask us also about OfftheShelf historical data. Come by the Evidera booth #241 or call to arrange a meeting.
#ESMOpic.twitter.com/l9NE8vKbwe
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Finalizing year end budgets and updating strategies? This is a good time to cross-check your data against our historical RWD available in 48 hours! Scan the QR code and let us know what your data needs are. Get 5% discount with the promo code LNKD2019
#RWD#onco-hematologypic.twitter.com/JRbkLUaxeQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join us at ESMO in Barcelona at the PPD Booth #241 in Hall 3. Discover our LiveTracker and OfftheShelf offerings in oncology and hematology.
#ESMO#PPD#oncologypic.twitter.com/JLxNUANh9l
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Last chance to register for the webinar on Recent Biomarker Impact in Cancer Management. To register send an email to webinar@medimix.net
#biomarkers#cancermangementpic.twitter.com/rfEdBIOaFl
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Medimix is going to ESMO with August RWD on CLL from our LiveTracker CLL. Ex. below: illustrates drugs that predominate in 1st Line treatment. RWE from more than 2,300 HCPS, EU5 and Brazil (Sept 2018-April 2019). More RWD available in oncology-hematology in 22+ indications.
#CLLpic.twitter.com/pZ2RXZm6hiHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Medimix is going to ESMO Congress Barcelona with the latest RWE from our syndicated LiveTracker Prostate Cancer. We've tracked prostate cancer patient journeys since 2016. Below - some recent findings on site metastasis by line of therapy (June 2018-2019).
#ESMO#mCRPCpic.twitter.com/OEq8oyyKpX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What inspires us at Medimix? Knowing that behind our work are patients fighting diseases and professionals dedicated to improving their health & quality of life. They are the source of our passion & our commitment to helping them reach their goals.
#beatcancer#LLSpic.twitter.com/iWcihaRGcDHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MM, is increasing worldwide with a highly variable incidence rate among different countries. Medimix LiveTracker MM has followed more than 2,100 patients in Germany (Aug '18-Jun'19). See patient shares by condition broken down below.
#MMSMpic.twitter.com/rpiJQWlly7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Medimix Int'l
@MedimixInt Aug 1 World Lung Cancer Day. Lung cancer continues to be one of the most common cancers worldwide, claiming more lives yearly than breast, colon and prostate cancers combined! Medimix LiveTracker Lung has RWE reported from EMRs on 32,000 patients.pic.twitter.com/cIZwyInBK2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
At the beach, mountains, year round--Sun protection (sun screen, protective clothing and limited time outdoors) is a must! Increasing ambient temperatures compound skin cancer risks. 5 yr. survival rate has increased, but melanoma is the most deadly skin cancer.
#RWD#melanomapic.twitter.com/I7FmDznYdx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Bladder cancer in LatAm - what's happening? Medimix LiveTracker Bladder delivers reliable RWD, with more than 3K patient records collected from May 2018 to May 2019. Some of results shown below. Ask us what other cancers we are tracking.
#oncology#bladdercancerpic.twitter.com/Z4zTi7pKm6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
DID YOU KNOW ... In a Medimix LiveTracker survey 1,826 oncologists responded that smoking is the most common risk factor both NSCLC and bladder. Smoking triples your chances of developing bladder cancer!
#bladdercancer#Bladdercancerawarepic.twitter.com/6UfFTILt9P
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The team at Medimix wishes you a Happy 4th of July. Or do you think of it as Independence Day? Either way, celebrate safely with family, friends and those you hold dear.pic.twitter.com/vCNzWvEmId
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join Medimix in a salute to all cancer survivors and families! Today there is increased hope as cancer death rates continue to decline, improved screenings find tumors earlier, and new targeted treatments are developed to use the body's own defenses.
#RWE#beatcancerpic.twitter.com/gtJVHndD6s
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Personalized Medicine for AML: Medimix LiveTracker AML is tracking changes in treatment options with drugs targeting mutations like FLT3 and IDH2. RWD available for US and EU5, with options for up to 50+ countries.
#FLT3#IDH2#RWEpic.twitter.com/a5MkwYsnS7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our Medimix team is looking for you at EHA! Let us show you a LiveTracker dashboard, with the latest real-time May RWD in a variety of hematology indications.pic.twitter.com/xLOBLz9KKH
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Medimix & Evidera are partnering to deliver real-time, RWE and insights to pharma, med device and diagnostic companies, leveraging data from Medimix's proprietary cloud-based visualization and analytics interface (LiveTracker). Join us at the PPD booth at ASCO
#PPD#BigData#RWEpic.twitter.com/TxvOfxivQB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.